SCOTT H KAUFMANN, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 37887
Category
Osteopathic Medicine
Type
Hematology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about SCOTT H KAUFMANN at bizstanding.comMayo Health System - Scott H Kaufmann MD
200 1 St SW, Rochester, MN 55905
Categories:
Physicians & Surgeons
Phone:
(507) 284-2511 (Phone)
Professional information
Scott H Kaufmann, Rochester MN
Specialties:
Oncologist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Johns Hopkins University - Doctor of Philosophy
Johns Hopkins Hospital - Fellowship - Oncology (Internal Medicine)
Johns Hopkins Hospital - Residency - Internal Medicine
Johns Hopkins University - Doctor of Philosophy
Johns Hopkins Hospital - Fellowship - Oncology (Internal Medicine)
Johns Hopkins Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Scott H Kaufmann, Rochester MN - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Internal Medicine, 1987, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1981
Johns Hopkins Hospital
Graduated: 1985
Graduated: 1987
Johns Hopkins University School Of Medicine
Graduated: 1981
Johns Hopkins Hospital
Graduated: 1985
Graduated: 1987
Scott Harold Kaufmann, Rochester MN
Specialties:
Internal Medicine, Medical Oncology, Hematology
Work:
Mayo Medical School
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
Johns Hopkins University (1981)
Methods And Materials For Assessing Enzyme-Nucleic Acid Complexes
US Patent:
8530172, Sep 10, 2013
Filed:
May 19, 2011
Appl. No.:
13/111583
Inventors:
Scott H. Kaufmann - Rochester MN, US
Anand G. Patel - Rochester MN, US
Anand G. Patel - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
G01N 33/53
US Classification:
435 71, 435 72
Abstract:
This document relates to methods and materials involved in assessing samples for enzyme-nucleic acid complexes. For example, methods and materials for using antibodies to determine the presence, absence, or amount of enzyme-nucleic acid complexes (e. g. , human topoisomerase I-DNA complexes) in a sample (e. g. , a biological sample such as a tissue biopsy) are provided.
Combination Of An Atp-Competitive Inhibitor Of Bcr/Abl Kinase Activity And A Tyrphostin Analog
US Patent:
2006005, Mar 16, 2006
Filed:
Oct 25, 2002
Appl. No.:
10/493788
Inventors:
Scott Kaufmann - Rochester MN, US
Benjamin Mow - Singapore, SG
Benjamin Mow - Singapore, SG
International Classification:
A61K 31/498, A61K 31/47, A61K 31/24
US Classification:
514249000, 514311000, 514534000
Abstract:
The present invention relates to a combination of (a) an ATP-competitive inhibitor of Bcr/abl kinase activity and (b)) a tyrphostin analog, and the use of said combination or product for the treatment of bcr/abl-related diseases.
Method Of Treating Mantle Cell Lymphoma
US Patent:
8507518, Aug 13, 2013
Filed:
Apr 1, 2011
Appl. No.:
13/078272
Inventors:
Thomas E. Witzig - Rochester MN, US
Scott H. Kaufmann - Rochester MN, US
Scott H. Kaufmann - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 31/44
US Classification:
514291
Abstract:
This invention provides the use of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of mantle cell lymphoma.
Method Of Treating Mantle Cell Lymphoma
US Patent:
2005011, May 26, 2005
Filed:
Nov 2, 2004
Appl. No.:
10/979284
Inventors:
Thomas Witzig - Rochester MN, US
Scott Kaufmann - Rochester MN, US
Scott Kaufmann - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K031/4745
US Classification:
514291000
Abstract:
This invention provides the use of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of mantle cell lymphoma.
Hsulf-1 Nucleic Acids, Polypeptides And Methods Of Using
US Patent:
2006010, May 11, 2006
Filed:
Dec 22, 2005
Appl. No.:
11/316132
Inventors:
Viji Shridhar - Rochester MN, US
Lewis Roberts - Rochester MN, US
Scott Kaufmann - Rochester MN, US
Lewis Roberts - Rochester MN, US
Scott Kaufmann - Rochester MN, US
International Classification:
A61K 38/17, C07K 14/82, C12Q 1/68, G01N 33/574, C07H 21/04, C12P 21/06, A61K 48/00
US Classification:
514012000, 435006000, 435069100, 435007230, 435320100, 435325000, 530350000, 536023500, 514044000
Abstract:
HSulf-1 nucleic acids and polypeptides are provided, as are methods of using the nucleic acids and polypeptides.